SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories informs about press release

07 Jun 2016 Evaluate

Alkem Laboratories has informed about a Press Release dated June 07, 2016 titled ‘Alkem announces closure of UK-MHRA inspection for its Bioequivalence Facility at Taloja’.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5662.75 162.75 (2.96%)
05-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1174.00
Cipla 1450.00
Lupin 2386.00
Zydus Lifesciences 1111.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: